Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder

Exclusion Criteria

• •Significant change in vital signs, medical history or concomitant medications since enrolling in the SOL-BED-301 study which, in the opinion of the Investigator or the Medical Monitor, would render the subject unsuitable to receive solriamfetol or participate in the study.